Bluecrest X Vista Health: A Clearer, Faster Pathway to Early Detection

Co-written by Dr. Martin Thornton (Bluecrest) and Vista Health

Prostate cancer is now the most commonly diagnosed cancer in men in the UK. According to Prostate Cancer UK, around 1 in 8 men will receive a diagnosis in their lifetime. Yet despite how widespread it is, many men delay conversations about prostate health; or avoid them altogether.

This UK Prostate Cancer Awareness Month, Vista Health and Bluecrest are joining forces to encourage men to take a proactive approach to their health. Early insight and timely access to diagnostic support can make a meaningful difference; together we’re committed to helping make that next step clearer and more accessible.

To support this, we’ve partnered to create a convenient onward pathway for individuals who receive an abnormal PSA result; providing rapid access to specialist consultation and advanced diagnostic imaging with clarity and transparency at every stage.

Plus, this month, get 10% off Bluecrest Male Cancer Risk packages, both of which include a PSA test.

Understanding PSA results

A Prostate-Specific Antigen (PSA) test measures the level of PSA in the blood. While raised levels don’t automatically indicate cancer; factors like age, inflammation, infection or benign enlargement can all play a role. They do, however, signal that further investigation may be appropriate.

For many men, the challenge isn’t the PSA test itself but what follows:

• Uncertainty can heighten anxiety

• Waiting times can delay reassurance

• Navigating next steps can feel confusing or overwhelming

This is why having a clear, structured pathway for follow?up matters.

Why early investigation is so important

Prostate cancer often develops slowly and may not produce symptoms in its early stages. When symptoms; such as changes in urinary habits; do appear, the condition may already be more advanced.

Key UK statistics highlight the importance of early action:

• Around 64,000 new cases are diagnosed each year

• Risk increases for men over 50

• Men with a family history have higher risk

• Black men face roughly double the lifetime risk

Prompt investigation, such as an MRI scan, after an abnormal PSA result can help clinicians:

• Rule out serious conditions

• Identify cancer at a more treatable stage

• Reduce avoidable delays

• Provide reassurance when cancer is not present

An abnormal PSA result shouldn’t cause panic; but it should encourage timely follow?up.

A faster, more convenient MRI pathway with Vista Health

Through our partnership, Bluecrest customers who receive an abnormal PSA result can access a streamlined onward pathway that prioritises speed, clarity and convenience.

Vista Health specialises in MRI and advanced diagnostic imaging, offering:

• Nationwide MRI clinics

• Flexible appointment times

• Rapid access to results

• Transparent pricing

• Support from expert GPs

For Bluecrest customers, this partnership provides:

• Initial GP consultation for £25 (saving 50%)

• 10% off MRI scans

This ensures that if further investigation is required, you can move forward without unnecessary delay and without navigating complex referral systems alone.

Why MRI is key in prostate investigation

• MRI plays a central role in evaluating prostate abnormalities and helps doctors: Identify whether a suspicious area is present

• Estimate the likelihood of clinically significant cancer

• Decide whether a biopsy is necessary

• Determine how urgently further action should be taken

Importantly, MRI can sometimes help men avoid unnecessary invasive procedures by clarifying risk early.

Quick access to high-quality imaging , supports better-informed decisions and improved outcomes.

Convenience and control

Barriers such as long waiting times, invasive examinations, inflexible appointments and disruption to daily life can discourage men from seeking follow?up care.

Our joint pathway is designed to address those barriers by offering:

• Painless, non-invasive scan to ease discomfort

• Appointment times that work around busy schedules

• Multiple accessible locations

• Clear communication at every stage

• A reduction in uncertainty and waiting

When dealing with a potential health concern, maintaining a sense of control is important; our approach aims to support that.

Prostate Cancer Awareness Month

UK Prostate Cancer Awareness Month is about normalising conversations, encouraging screening discussions and reducing stigma.

If you’re:

• Over 50

• Over 45 with a family history

• Black and over 45

• Experiencing urinary changes

It may be time to speak to a clinician about PSA testing.

And if your results indicate further investigation is needed, our partnership with Vista Health ensures you can take the next step quickly and confidently.

This Prostate Cancer Awareness Month also marks an important moment for research that could change the future of prostate cancer diagnosis. The TRANSFORM trial, funded and led by Prostate Cancer UK, is the biggest prostate cancer screening trial in more than two decades, designed to find the best way to screen men for prostate cancer and ultimately save thousands of lives every year.

The study will test multiple approaches, including PSA blood tests and fast MRI scans, in a large-scale comparison to current diagnostic methods, with the aim of identifying aggressive cancers early and with fewer unnecessary procedures.

If successful, TRANSFORM could provide the definitive evidence needed to introduce a national prostate cancer screening programme, moving the UK closer to a future where early detection is routine rather than by chance.

A shared commitment

Together, our organisations share a commitment to making preventative healthcare more accessible, more transparent and less stressful.

By combining early health insights with rapid access to advanced diagnostics, we aim to help men move from uncertainty toward clarity; with expert support throughout the process.

Prostate cancer may affect one in eight men; but with early action, modern imaging and a clear pathway, outcomes can be significantly improved.

This Prostate Cancer Awareness Month, we encourage men to take proactive steps for their health; and to know that if further investigation is needed, a trusted pathway is already in place.